| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 45 | 22 | 22 | 199 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -45 | -22 | -22 | -199 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -45 | -22 | -22 | -199 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ammodytes Venom Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 209 | 207 | 203 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 19.390 | 19.170 | 18.823 | 13.623 | 13.359 | 13.106 | 12.816 | 12.855 | 12.816 | 12.745 |
| Inventories | 14.308 | 14.162 | 13.923 | 13.667 | 13.402 | 13.148 | 12.857 | 12.897 | 12.858 | 12.786 |
| Receivables | 5.049 | 4.998 | 4.913 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 32 | 9 | -13 | -44 | -43 | -42 | -41 | -41 | -41 | -41 |
| Shareholders Funds | -139 | -160 | -179 | -375 | -368 | -361 | -353 | -354 | -353 | -351 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.737 | 19.536 | 19.206 | 13.998 | 13.727 | 13.467 | 13.169 | 13.209 | 13.169 | 13.096 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "149 - 149" | |||||||||
| CAEN Financial Year |
149
|
|||||||||
Comments - Ammodytes Venom Srl